BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7877583)

  • 1. [Clinical and experimental studies of septic DIC in surgical patients, in terms of its characteristic features and pathogenesis].
    Ono S
    Nihon Geka Gakkai Zasshi; 1994 Dec; 95(12):849-59. PubMed ID: 7877583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery.
    Ono S; Mochizuki H; Tamakuma S
    Am J Surg; 1996 Apr; 171(4):409-15. PubMed ID: 8604832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC.
    Ono S; Tamakuma S; Mochizuki H; Kinoshita M; Ohkusa Y; Aosasa S; Oda Y; Ohe H
    Surg Today; 1993; 23(3):228-33. PubMed ID: 8467174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disseminated intravascular coagulation induced by endotoxin in rabbits: effect of treatment with t-PA and urokinase].
    Paloma MJ; Páramo JA; Rifón J; Rocha E
    Sangre (Barc); 1992 Dec; 37(6):435-8. PubMed ID: 1293794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental studies on the relation of platelet activating factor (PAF) to high mortality in sublethal endotoxemia after massive hepatectomy and effects of its antagonist].
    Onuki Y; Nakamura S; Muro H; Baba S
    Nihon Geka Gakkai Zasshi; 1993 May; 94(5):466-74. PubMed ID: 8332121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis in disseminated intravascular coagulation.
    Hack CE
    Semin Thromb Hemost; 2001 Dec; 27(6):633-8. PubMed ID: 11740686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential etiologic role of PAF in two major septic complications; disseminated intravascular coagulation and multiple organ failure.
    Ou MC; Kambayashi J; Kawasaki T; Uemura Y; Shinozaki K; Shiba E; Sakon M; Yukawa M; Mori T
    Thromb Res; 1994 Feb; 73(3-4):227-38. PubMed ID: 8191415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor activity in bacterial infection.
    Páramo JA; Fernández Diaz FJ; Rocha E
    Thromb Haemost; 1988 Jun; 59(3):451-4. PubMed ID: 3142082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator antigen and activity in disseminated intravascular coagulation: clinicopathologic correlations.
    Francis RB; Seyfert U
    J Lab Clin Med; 1987 Nov; 110(5):541-7. PubMed ID: 3117952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
    Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
    Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
    Mosad E; Elsayh KI; Eltayeb AA
    Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
    Voves C; Wuillemin WA; Zeerleder S
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
    Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood coagulation and fibrinolytic factors as well as their inhibitors in trauma.
    Blombäck M; Eklund J; Hellgren M; Lagerkranser M; Swedenborg J
    Scand J Clin Lab Invest Suppl; 1985; 178():15-23. PubMed ID: 3867116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global fibrinolytic capacity in pediatric patients with sepsis and disseminated intravascular coagulation.
    Bay A; Oner AF; Kose D; Dogan M
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):569-73. PubMed ID: 16988553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome.
    Gando S; Kameue T; Nanzaki S; Nakanishi Y
    Thromb Haemost; 1996 Feb; 75(2):224-8. PubMed ID: 8815564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock.
    Vervloet MG; Thijs LG; Hack CE
    Semin Thromb Hemost; 1998; 24(1):33-44. PubMed ID: 9515778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemorrhagic syndrome induced by caterpillars. Clinical and experimental studies. Review].
    Arocha-Piñango CL; Guerrero B
    Invest Clin; 2003 Jun; 44(2):155-63. PubMed ID: 12815846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.